Early research (Phase 1)Study completedNCT02171832
What this trial is testing
Single Dose of BI 1744 CL in Patients With Mild and Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function
Who this might be right for
HealthyLiver Diseases
Boehringer Ingelheim 32